Length of time on peritoneal dialysis and encapsulating peritoneal sclerosis: Position paper for ISPD

Peritoneal Dialysis International

Volumn 29, Issue 6, 2009, Pages 595-600

  Brown, Edwina A ^a   van Biesen, Wim ^b   Finkelstein, Fredric O ^c   Hurst, Helen ^d   Johnson, David W ^e   Kawanishi, Hideki ^f   Pecoits Filho, Roberto ^g   Woodrow, Graham ^h  

^a HAMMERSMITH HOSPITAL   (United Kingdom)

^b GHENT UNIVERSITY HOSPITAL   (Belgium)

^c YALE UNIVERSITY   (United States)

^d MANCHESTER ROYAL INFIRMARY   (United Kingdom)

^e PRINCESS ALEXANDRA HOSPITAL   (Australia)

^f TSUCHIYA GENERAL HOSPITAL   (Japan)

^g PONTIFICAL CATHOLIC UNIVERSITY OF PARANÁ   (Brazil)

^h ST JAMES S UNIVERSITY HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE;

ARTICLE; CLINICAL FEATURE; COMORBIDITY; COMPUTER ASSISTED TOMOGRAPHY; DIALYSATE; ENCAPSULATING PERITONEAL SCLEROSIS; HEMODIALYSIS; HUMAN; INCIDENCE; LAPAROSCOPY; LIFE EXPECTANCY; PATIENT SELECTION; PERITONEAL DIALYSIS; PERITONEAL DISEASE; PERITONITIS; PRIORITY JOURNAL; PROGNOSIS; QUALITY OF LIFE; RADIODIAGNOSIS; RISK ASSESSMENT; RISK FACTOR; SCLEROSIS; SYMPTOM;

EID: 77950882878     PISSN: 08968608     EISSN: 17184304     Source Type: Journal    
DOI: 10.1177/089686080902900602     Document Type: Article

References (30)

1. Johnson DW, Excell L, Livingston B, Bannister K, McDonald S. Peritoneal Dialysis. ANZDATA Registry Report 2008. Adelaide, South Australia: Australia and New Zealand Dialysis and Transplant Registry; 2008:6-1-6-17.
2. Han SH, Lee JE, Kim DK, Moon SJ, Kim HW, Chang JH, et al. Long-term clinical outcomes of peritoneal dialysis patients: single center experience from Korea. Perit Dial Int 2008; 28(Suppl 3):S21-6.
3. Brown EA, Davies SJ, Rutherford P, Meeus F, Borras M, Riegel W, et al.; on behalf of EAPOS Group. Survival of functionally anuric patients on automated peritoneal dialysis: the European APD Outcome Study (EAPOS). J Am Soc Nephrol 2003; 14:2948-57.
4. Rigby R, Hawley C. Sclerosing peritonitis: the experience in Australia. Nephrol Dial Transplant 1998; 13:154-9.
5. Balasubramaniam G, Brown EA, Davenport A, Cairns H, Cooper B, Fan SLS, et al. Clinical course and management of encapsulating peritoneal sclerosis: a multicentre retrospective survey from the UK. Nephrol Dial Transplant 2009; 24:3209-15; doi:10.1093/ndt/gfp008.
6. Brown MC, Simpson K, Kerssens J, MacTier R; on behalf of the Scottish Renal Registry. Encapsulating peritoneal sclerosis in the new millennium: a national cohort study. Clin J Am Soc Nephrol 2009; 4:1222-9.
7. Nomoto Y, Kawaguchi Y, Kubo H, Hirano H, Sakai S, Kurokawa K. Sclerosing encapsulating peritonitis in patients undergoing continuous ambulatory peritoneal dialysis: a report of the Japanese Sclerosing Encapsulating Peritonitis Study Group. Am J Kidney Dis 1996; 28:420-7.
8. Kawanishi H, Kawaguchi Y, Fukui H, Hara S, Imada A, Kubo H, et al.; for the Long-Term Peritoneal Dialysis Study Group. Encapsulating peritoneal sclerosis in Japan: a prospective, controlled, multicenter study. Am J Kidney Dis 2004; 44:729-37.
9. Korte MR, Yo M, Betjes MG, Fieren MW, van Saase JCLM, Boer WH, et al. Increasing incidence of severe encapsulating peritoneal sclerosis after kidney transplantation. Nephrol Dial Transplant 2002; 22:2412-14.
10. Summers AM, Clancy MJ, Syed F, Harwood N, Brenchley PE, Augustine T, et al. Single-center experience of encapsulating peritoneal sclerosis in patients on peritoneal dialysis for end-stage renal failure. Kidney Int 2005; 68:2381-8.
11. Fieren MW, Betjes MG, Korte MR, Boer WH. Posttransplant encapsulating peritoneal sclerosis: a worrying trend? Perit Dial Int 2007; 27:619-24.
12. Kawaguchi Y, Saito A, Kawanishi H, Nakayama M, Miyazaki M, Nakamoto H, et al. Recommendations on the management of encapsulating peritoneal sclerosis in Japan, 2005: diagnosis, predictive markers, treatment, and preventive measures. Perit Dial Int 2005; 25(Suppl 4):S83-95.
13. Spiers C, Madison JR, Schatz IJ. Infective endocarditis in patients with end-stage renal disease. Clinical presentation and outcome. Arch Intern Med 2004; 164:71-5.
14. Mokrzycki MH, Zhang M, Cohen H, Golestaneh L, Laut JM, Rosenberg SO. Tunnelled haemodialysis catheter bacteraemia: risk factors for bacteraemia recurrence, infectious complications and mortality. Nephrol Dial Transplant 2006; 21:1024-31.
15. Nakamoto H. Encapsulating peritoneal sclerosis-a clinician's guide to diagnosis and medical management. Perit Dial Int 2005; 25(Suppl 4):S30-8.
16. Hur J, Kim KW, Park MS, Yu JS. Abdominal cocoon: preoperative diagnostic clues from radiologic imaging and pathologic correlation. AJR Am J Roentgenol 2004; 182:639-41.
17. Tarzi RM, Lim A, Moser S, Ahmed S, George A, Balasubramaniam G, et al. Assessing the validity of an abdominal CT scoring system as an aid to the diagnosis of encapsulating peritoneal sclerosis. Clin J Am Soc Nephrol 2008; 3:1702-10.
18. Honda K, Oda H. Pathology of encapsulating peritoneal sclerosis. Perit Dial Int 2005; 25(Suppl 4):S19-29.
19. Krediet RT, Struijk DG, Boeschoten EW, Koomen GC, Stouthard JM, Hoek FJ, et al. The time course of peritoneal transport kinetics in continuous ambulatory peritoneal dialysis patients who develop sclerosing peritonitis. Am J Kidney Dis 1989; 4:299-307.
20. Yamamoto R, Nakayama M, Hasegawa T, Miwako N, Yamamoto H, Yokoyami K, et al. High-transport membrane is a risk factor for encapsulating peritoneal sclerosis developing after long-term continuous ambulatory peritoneal dialysis. Adv Perit Dial 2002; 18:131-4.
21. Moriishi M, Kawanishi H, Kawai T, Takahashi S, Hirai T, Shishida M, et al. Preservation of peritoneal catheter for prevention of encapsulating peritoneal sclerosis. Adv Perit Dial 2002; 18:149-53.
22. Kuriyama S, Tomonari H. Corticosteroid therapy in encapsulating peritoneal sclerosis. Nephrol Dial Transplant 2001; 16:1304-5.
23. Eltoum MA, Wright S, Atchley J, Mason JC. Four consecutive cases of peritoneal dialysis-related encapsulating peritoneal sclerosis treated successfully with tamoxifen. Perit Dial Int 2006; 26:203-6.
24. Junor BJR, McMillan MA. Immunosuppression in sclerosing peritonitis. Adv Perit Dial 1993; 9:187-9.
25. Rajani R, Smyth J, Koffman CG, Abbs I, Goldsmith DJ. Differential effect of sirolimus vs prednisolone in the treatment of sclerosing encapsulating peritonitis. Nephrol Dial Transplant 2007; 17:2278-80.
26. Lafrance JP, Letourneau I, Ouimet D, Bonnardeaux A, Leblanc M, Mathieu N, et al. Successful treatment of encapsulating peritoneal sclerosis with immunosuppressive therapy. Am J Kidney Dis 2008; 51:7-10.
27. Kawanishi H, Watanabe H, Moriishi M, Tsuchiya S. Successful surgical management of encapsulating peritoneal sclerosis. Perit Dial Int 2005; 25(Suppl 4):S39-47.
28. Kawanishi H, Moriishi M, Ide K, Dohi K. Recommendation of the surgical option for treatment of encapsulating peritoneal sclerosis. Perit Dial Int 2008; 28(Suppl 3):S205-10.
29. de Freitas DG, Augustine T, Brown EA, Brenchley PEC, Collinson H, Davenport A, et al.; (UK EPS Group). Encapsulating peritoneal sclerosis following renal transplantation- the UK experience. Am J Transplant 2007; 7(Suppl 2):163.
30. Hawley CM, Wall DR, Johnson DW, Campbell SB, Griffin AD, Rigby RJ, et al. Recovery of gastrointestinal function after renal transplantation in a patient with sclerosing peritonitis secondary to continuous ambulatory peritoneal dialysis. Am J Kidney Dis 1995; 26:658-61.